Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?-Reference-Cited by-同舟云学术

Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?

Published:2019-05 Issue:2 Volume:153 Page:277-285
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Mora Paulo Alexandre Ribeiro,Sun Sue Yazaki,Velarde Guillermo Coca,Filho Jorge Rezende,Uberti Elza H.,dos Santos Esteves Ana Paula Vieira,Elias Kevin M.,Horowitz Neil S.,Braga Antonio,Berkowitz Ross S.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference36 articles.

1. Update on the diagnosis and management of gestational trophoblastic disease;Ngan;Int. J. Gynaecol. Obstet.,2018

2. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study;Dantas;J. Reprod. Med.,2012

3. Brazilian network for gestational trophoblastic disease study group consensus on management of gestational trophoblastic disease;Braga;J. Reprod. Med.,2018

4. First-line chemotherapy in low-risk gestational trophoblastic neoplasia;Lawrie;Cochrane Database Syst. Rev.,2016

5. High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults;Lotz;Cancer,1995

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy analysis of single-agent carboplatin AUC4 2-weekly as second-line therapy for methotrexate-resistant (MTX-R) low risk gestational trophoblastic neoplasia (GTN);Gynecologic Oncology;2023-08

2. Sonographic Diagnosis and Management With Delayed Hysterectomy of Two Cesarean Scar Pregnancies That Developed Into Placenta Percreta: Two Case Reports;Cureus;2023-04-04

3. Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian cases;Clinics;2023-01

4. Current chemotherapeutic options for the treatment of gestational trophoblastic disease;Expert Opinion on Pharmacotherapy;2022-11-27

5. Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia;Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics;2022-06-27